Call for Public Review

To get complete public review, the AHRQ TA Program will post draft reports on the AHRQ TA Web site. To meet the timelines for Medicare coverage decisions mandated by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, draft technology assessment reports will be available for public review for a limited time. A notice will be sent out on the AHRQ Effective Health Care email distribution list 1 week before the posting of draft reports. Each report will be available for public review on this website for a total of 3 weeks.

AHRQ's TA Program supports and is committed to the transparency of its review process. Therefore, starting March 18, 2009, invited peer review comments and public review comments will be publicly posted on the TA Program website within 3 months after the associated final report is posted on this website. The report authors' responses to the comments (the "disposition of comments") will be posted on the same Web page as the associated comments.

Currently Available for Review

None available at this time.

Review Steps

When a draft Technology Assessment report is available for review, you may review the draft report by completing the associated review form and then selecting "Submit" on the form.

Note: Comments received after the review period will not be accepted.

Disclosure Policy for AHRQ Technology Assessment Program Public Review

Original Implementation Date: March 12, 2009; Most Recent Revision: November 19, 2013

The AHRQ Technology Assessment (TA) Program supports and is committed to the transparency of its public review process. Review comments that are submitted in response to a public review announcement and received during a draft report review period will be publicly posted to the TA Program within 3 months after the associated final report is posted on this website. Each review comment will be listed with the reviewer’s name and affiliation, if such information is provided. Reviewers are not required to provide their name or affiliation in order to submit comments. Please note that if reviewers include identifiable personal health information, it will be redacted. The report authors’ responses to the comments (the “disposition of comments”) will be posted on the same webpage as the associated comments.

Questions

Please contact epc@ahrq.hhs.gov if you have any questions.